Literature DB >> 15603293

The biological basis of fractionation.

Karin Haustermans1, H Rodney Withers.   

Abstract

A few important concepts in radiobiology are illustred. The cell survival, the concept of the biologically effective dose, the basis of fractionation in radiotherapy are considered. Slow tumor regression after irradiation is not an indication of treatment failure, and the rate of regression is not , in general, prognostic. Dose volume histograms provide many data for predicting tumor control and side effects. The magnitude of a dose reduction in the tumor is the major determinant of decline in tumor control probability. Escalation of dose to hypoxic foci may be beneficial. Basic knowledge of these concepts is essential for daily radiotherapy practice and for all radiation oncologists.

Entities:  

Mesh:

Year:  2004        PMID: 15603293

Source DB:  PubMed          Journal:  Rays        ISSN: 0390-7740


  4 in total

Review 1.  The impact on oncology of the interaction of radiation therapy and radiobiology.

Authors:  Vicente Pedraza Muriel
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

Review 2.  Acetabular fixation in total hip arthroplasty in the previously irradiated pelvis: a review of basic science and clinical outcomes.

Authors:  John Patrick Connors; Patrick Garvin; Jacob Silver; Adam Lindsay; Olga Solovyova
Journal:  Arch Orthop Trauma Surg       Date:  2022-08-19       Impact factor: 2.928

3.  Stereotactic radiotherapy for large vestibular schwannomas: Volume change following single fraction versus hypofractionated approaches.

Authors:  Michael Huo; Heath Foley; Mark Pinkham; Mihir Shanker; Anne Bernard; Michael Jenkins; Sarah Olson; Bruce Hall; Trevor Watkins; Catherine Jones; Matthew Foote
Journal:  J Radiosurg SBRT       Date:  2020

4.  The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction.

Authors:  David J Brenner
Journal:  Semin Radiat Oncol       Date:  2008-10       Impact factor: 5.934

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.